Dear BB,

I hope you can help. I have been trying to density modify my potential SAD 
solutions but I think it would help if I could conceptualize the arrangement of 
molecules in my crystals and it is making my head hurt.

I have 2 crystal forms. I  only obtained a single crystal for the first form 
which I have never been able to reproduce. It processes well to ~3A in 
P6122/P6522 (a=52.3, b=52.3, c=216.9; 1 mol/AU) and C2221 (a=52.3, b=90.5, 
c=216.9; 3 mol/AU), systematic absences are convincing and there does not look 
like any twinning issues. MR has not worked but the closest model has less than 
20% similarity. A self rotation function shows strong peaks along x, y and z 
(k=180) and weaker ones along z (k=60 and 120).

In a slightly altered condition I can obtain reproducible crystals although the 
space group has now changed. I have collected native and iodide-SAD data to 
~3.2A on these crystals which now index in P222. Systematic absences suggest 
they are P212121 (a=52.61, b=88.261, c=212.072 in the SAD data), however, they 
contain pseudotranslational NCS (0.5,0.5,0.03) which is ~40% of the origin, so 
it may be another choice of P222. The self rotation function is similar to the 
previous data. As these cell dimensions and that of the C2221 data are almost 
identical it looks like there has been a slight shift in the lattice 
arrangement causing the pseudotranslational symmetry (therefore 6 mols/AU). The 
native and SAD data are isomorphous within 1% but I get much better statistics 
from phasing with SAD alone. The anomalous signal is reasonable to 4.5-5A but I 
do get some potential solutions using PHENIX (FOMs ~0.5, BAYES-CC ~40, scew 
10-20). Whilst I can see solvent/protein boundaries, at this resolution it is 
hard to tell what is going on and I am finding it hard to trace any sheets (it 
is an Ig-like fold) and I think some NCS averaging may do a world of good.

The problem is how do I apply this with  improper NCS - i.e. how is the 6-fold 
NCS from the self rotation related to the translational NCS. Also am I missing 
something which is blatantly obvious which can help me improve these maps and 
hopefully push the resolution out to its full potential. I might be asking for 
a lot with this data but if you can help it would be much appreciated - and if 
I have left out any details please ask away.

Many thanks

James

Dr James Garnett
Division of Molecular Biosciences,
Imperial College London
Level 5, Biochemistry Building,
South Kensington,
LONDON,
SW7 2AZ,
UK.

 

Reply via email to